Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Per Ljungman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Living Beings

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Europe

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
82
Ringdén, Olle
52
Aschan, Johan
44
Lönnqvist, B
38
Remberger, Mats
29
Winiarski, Jacek
22
Gahrton, Gösta
20
Mattsson, Jonas
19
Hägglund, Hans
16
Oberg, Gunnar
14
Björkstrand, Bo
13
Bacigalupo, Andrea
13
Barkholt, Lisbeth
13
Klaesson, S
12
Pauksen, Karlis
12
Sparrelid, Elda

Sign-in to see all Coauthors

Publications

TOP 3
Ljungman P; Cordonnier C; Einsele H; Englund J; Machado C M; Storek J; Small T
Vaccination of hematopoietic cell transplant recipients.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Le Blanc Katarina; Barrett A John; Schaffer Marie; Hägglund Hans; Ljungman Per; Ringdén Olle; Remberger Mats
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Per Ljungman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ljungman P; Cordonnier C; Einsele H; Englund J; Machado C M; Storek J; Small T
Vaccination of hematopoietic cell transplant recipients.
Bone marrow transplantation 2009;44(8):521-6.
2009: Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):393-9.
2009: Le Blanc Katarina; Barrett A John; Schaffer Marie; Hägglund Hans; Ljungman Per; Ringdén Olle; Remberger Mats
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1108-15.
2008: Nahi H; Jansson M; Sander B; Ljungman P; Hägglund H
Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient.
British journal of haematology 2008;143(5):751-3.
2008: Ljungman P
CMV infections after hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;42 Suppl 1():S70-S72.
2008: Ljungman P; de la Camara R; Cordonnier C; Einsele H; Engelhard D; Reusser P; Styczynski J; Ward K;
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.
Bone marrow transplantation 2008;42(4):227-40.
2008: Avetisyan Gayane; Aschan Johan; Hassan Moustapha; Ljungman Per
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation.
Transplantation 2008;86(2):257-63.
2008: Edvinsson Benjamin; Lundquist Jessica; Ljungman Per; Ringdén Olle; Evengård Birgitta
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(5):345-51.
2008: Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
Bone marrow transplantation 2008;41(8):737-42.
2008: Westling Katarina; Julander Inger; Ljungman Per; Vondracek Martin; Wretlind Bengt; Jalal Shah
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpB.
The Journal of infection 2008;56(3):204-10.
2008: Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Bone marrow transplantation 2008;41(3):267-73.
2008: Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof E T; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy A N; Fuehrer M; Maury S; Schrezenmeier H; van Lint M T; Wojcik D; Locasciulli A; Passweg J R
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
Bone marrow transplantation 2008;41(1):45-50.
2007: Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;40(11):1055-62.
2007: Avetisyan G; Aschan J; Hägglund H; Ringdén O; Ljungman P
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.
Bone marrow transplantation 2007;40(9):865-9.
2007: Ljungman Per; Brandan Ronald
Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors.
Haematologica 2007;92(8):1139-42.
2007: Ljungman Per
Risk assessment in haematopoietic stem cell transplantation: viral status.
Best practice & research. Clinical haematology 2007;20(2):209-17.
2007: Ringdén O; Remberger M; Svenberg P; Svahn B-M; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2007: Deneberg Stefan; Lerner Richard; Ljungman Per; Ringden Olle; Hägglund Hans
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?
Medical oncology (Northwood, London, England) 2007;24(3):354-6.
2006: Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.
Bone marrow transplantation 2006;38(10):687-92.
2006: Olsson-Strömberg Ulla; Höglund Martin; Björkholm Magnus; Braide Inger; Carlson Karin; Gahrton Gösta; Grimfors Gunnar; Hast Robert; Lerner Rickard; Linder Olle; Ljungman Per; Löfvenberg Eva; Malm Claes; Nilsson Per-Gunnar; Paul Christer; Rödjer Stig; Stenke Leif; Tidefeldt Ulf; Turesson Ingemar; Uden Ann-Marie; Wahlin Anders; Vilen Lars; Winqvist Ingemar; Zettervall Olle; Oberg Gunnar; Simonsson Bengt
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Leukemia & lymphoma 2006;47(9):1768-73.
2006: Ljungman Per
Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):493-5.
2006: Ringdén Olle; Remberger Mats; Svahn Britt-Marie; Barkholt Lisbeth; Mattsson Jonas; Aschan Johan; Le Blanc Katarina; Gustafsson Britt; Hassan Zuzana; Omazic Brigitta; Svenberg Petter; Solders Göran; von Döbeln Ulrika; Winiarski Jacek; Ljungman Per; Malm Gunilla
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2006: Giraud Géraldine; Bogdanovic Gordana; Priftakis Peter; Remberger Mats; Svahn Britt-Marie; Barkholt Lisbeth; Ringden Olle; Winiarski Jacek; Ljungman Per; Dalianis Tina
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen.
Haematologica 2006;91(3):401-4.
2006: Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2006;37(5):439-49.
2006: Ljungman Per; Perez-Bercoff Lena; Jonsson Jerker; Avetisyan Gayane; Sparrelid Elda; Aschan Johan; Barkholt Lisbeth; Larsson Kajsa; Winiarski Jacek; Yun Zhibing; Ringdén Olle
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
Haematologica 2006;91(1):78-83.
2005: Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C;
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
Bone marrow transplantation 2005;35(8):737-46.
2005: Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron J M; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell N H; Samson D; Schattenberg A; Sirohi B; Verdonck L F; Volin L; Zander A; Niederwieser D
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
Bone marrow transplantation 2005;35(6):609-17.
2005: Simonsson Bengt; Oberg Gunnar; Bjoreman Mats; Bjorkholm Magnus; Carneskog Jan; Karlsson Karin; Gahrton Gosta; Grimfors Gunnar; Hast Robert; Karle Hans; Linder Olle; Ljungman Per; Nielsen Johan L; Nilsson Jonas; Lofvenberg Eva; Malm Claes; Olsson Karin; Olsson-Stromberg Ulla; Paul Christer; Stenke Leif; Stentoft Jesper; Turesson Ingemar; Udén Ann-Marie; Wahlin Anders; Vilén Lars; Weis-Bjerrum Ole
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Acta haematologica 2005;113(3):155-62.
2005: Ljungman Per; von Döbeln Lovisa; Ringholm Lotta; Lewensohn-Fuchs Ilona; Klingspor Lena; Sparrelid Elda
The value of CMV and fungal PCR for monitoring for acute leukaemia and autologous stem cell transplant patients.
Scandinavian journal of infectious diseases 2005;37(2):121-7.
2004: Svenberg Petter; Remberger Mats; Svennilson Johan; Mattsson Jonas; Leblanc Katarina; Gustafsson Britt; Aschan Johan; Barkholt Lisbeth; Winiarski Jacek; Ljungman Per; Ringdén Olle
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients.
Bone marrow transplantation 2004;34(12):1067-9.
2004: Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Journal of clinical microbiology 2004;42(11):5394-6.
2004: Ljungman P; Aschan J; Barkholt L; Broliden P-A; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease.
Bone marrow transplantation 2004;34(7):589-93.
2004: Ljungman P; Reusser P; de la Camara R; Einsele H; Engelhard D; Ribaud P; Ward K;
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.
Bone marrow transplantation 2004;33(11):1075-81.
2004: Ljungman Per
Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
British journal of haematology 2004;125(2):107-16.
2004: Nordlander Anna; Mattsson Jonas; Ringdén Olle; Leblanc Katarina; Gustafsson Britt; Ljungman Per; Svenberg Petter; Svennilson Johan; Remberger Mats
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2004: Ringdén Olle; Schaffer Marie; Le Blanc Katarina; Persson Ulla; Hauzenberger Dan; Abedi Mohammad R; Olerup Olle; Ljungman Per; Remberger Mats
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):128-34.
2004: Olsson-Strömberg Ulla; Simonsson Bengt; Ahlgren Tomas; Björkholm Magnus; Carlsson Karin; Gahrton Gösta; Hast Robert; Löfvenberg Eva; Linder Olle; Ljungman Per; Malm Claes; Paul Christer; Rödjer Stig; Turesson Ingemar; Udén Ann-Mari; Wahlin Anders; Killander Andreas; Wadman Bengt; Westin Jan; Vikrot Olle; Zettervall Olle; Oberg Gunnar;
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(6):462-6.
2004: Cherif Honar; Björkholm Magnus; Engervall Per; Johansson Peter; Ljungman Per; Hast Robert; Kalin Mats
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Scandinavian journal of infectious diseases 2004;36(8):593-600.
2004: Ljungman Per
Viral infections: current diagnosis and treatment.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5 Suppl 3():S63-8.
2003: Ljungman Per; Brand Ronald; Einsele Hermann; Frassoni Francesco; Niederwieser Dietger; Cordonnier Catherine
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
Blood 2003;102(13):4255-60.
2003: Ljungman P; Wang F Z; Nilsson C; Solheim V; Linde A
Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(11):739-41.
2003: Yun Zhibing; Lewensohn-Fuchs Ilona; Ljungman Per; Ringholm Lotta; Jonsson Jerker; Albert Jan
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients.
Journal of virological methods 2003;110(1):73-9.
2003: Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C;
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 2003;31(6):481-6.
2003: Nilsson C; Aschan J; Hentschke P; Ringdén O; Ljungman P; Hassan M
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(6):429-35.
2002: Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Bone marrow transplantation 2002;30(12):833-41.
2002: Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
Bone marrow transplantation 2002;30(11):761-8.
2002: Wang F-Z; Larsson K; Linde A; Ljungman P
Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
Bone marrow transplantation 2002;30(8):521-6.
2002: Ruutu Tapani; Hermans Jo; Niederwieser Dietger; Gratwohl Alois; Kiehl Michael; Volin Liisa; Bertz Harmut; Ljungman Per; Spence David; Verdonck Leo F; Prentice H Grant; Bosi Alberto; Du Toit Cecile E; Brinch Lorentz; Apperley Jane F;
Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(4):1112-9.
2002: Axdorph Ulla; Stenke Leif; Grimfors Gunnar; Carneskog Jan; Hansen Jan; Linder Olle; Ljungman Per; Löfvenberg Eva; Malm Claes; Simonsson Bengt; Turesson Ingemar; Vilén Lars; Udén Anne-Marie; Björkholm Magnus;
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.
British journal of haematology 2002;118(4):1048-54.
2002: Ljungman Per
Prevention and treatment of viral infections in stem cell transplant recipients.
British journal of haematology 2002;118(1):44-57.
2002: Larsson Kajsa; Lönnqvist B; Ringdén O; Hedquist B; Ljungman P
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
Transplant infectious disease : an official journal of the Transplantation Society 2002;4(2):75-9.
2002: Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2002;29(8):639-46.
2002: Ljungman Per; de La Camara Rafael; Milpied Noel; Volin Liisa; Russell Charlotte A; Crisp Adam; Webster Alison;
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
Blood 2002;99(8):3050-6.
2002: Ljungman Per; Griffiths Paul; Paya Carlos
Definitions of cytomegalovirus infection and disease in transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(8):1094-7.
2002: Hentschke Patrik; Remberger Mats; Mattsson Jonas; Barkholt Lisbeth; Aschan Johan; Ljungman Per; Ringdén Olle
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Transplantation 2002;73(6):930-6.
2002: Remberger Mats; Kumlien Gunilla; Aschan Johan; Barkholt Lisbeth; Hentschke Patrik; Ljungman Per; Mattsson Jonas; Svennilson Johan; Ringdén Olle
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):674-82.
2002: Ljungman Per; Larsson Kajsa; Kumlien Gunilla; Aschan Johan; Barkholt Lisbeth; Gustafsson-Jernberg Asa; Lewensohn-Fuchs Ilona; Ringdén Olle
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors.
Scandinavian journal of infectious diseases 2002;34(5):347-50.
2001: Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell N H; Samson D; Schaefer U W; Schattenberg A; Tura S; Verdonck L F; Vernant J P; Willemze R; Volin L;
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
British journal of haematology 2001;113(1):209-16.
2001: Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen J J; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone A H; San Miguel J; Schattenberg A; Gahrton G
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2001;27(5):511-5.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
2001: Ljungman P; Deliliers G L; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann A J; Wacker P; Cordonnier C
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2001;97(2):388-92.
2001: Ljungman P
Respiratory virus infections in stem cell transplant patients: the European experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7 Suppl():5S-7S.
2001: Ljungman P
Prophylaxis against herpesvirus infections in transplant recipients.
Drugs 2001;61(2):187-96.
2000: Ljungman P; Wang F Z; Clark D A; Emery V C; Remberger M; Ringdén O; Linde A
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
British journal of haematology 2000;111(3):774-81.
2000: Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi D V; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
Journal of medical virology 2000;62(4):498-504.
2000: de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet J P; Arnold R; Apperley J
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2000;110(3):620-30.
2000: Hassan M; Svensson J O; Nilsson C; Hentschke P; Al-Shurbaji A; Aschan J; Ljungman P; Ringdén O
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy.
Therapeutic drug monitoring 2000;22(4):383-5.
2000: Lehmann S; Isberg B; Ljungman P; Paul C
Cardiac systolic function before and after hematopoietic stem cell transplantation.
Bone marrow transplantation 2000;26(2):187-92.
2000: Yun Z; Lewensohn-Fuchs I; Ljungman P; Vahlne A
Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays.
Transplantation 2000;69(8):1733-6.
2000: Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.
Transplantation 2000;69(8):1582-6.
2000: Pauksen K; Linde A; Hammarström V; Sjölin J; Carneskog J; Jonsson G; Oberga G; Engelmann H; Ljungman P
Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):342-8.
2000: Gustafsson A; Levitsky V; Zou J Z; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci M G
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Blood 2000;95(3):807-14.
2000: Bacigalupo A; Brand R; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.
Seminars in hematology 2000;37(1):69-80.
2000: Guardiola P; Pasquini R; Dokal I; Ortega J J; van Weel-Sipman M; Marsh J C; Ball S E; Locatelli F; Vermylen C; Skinner R; Ljungman P; Miniero R; Shaw P J; Souillet G; Michallet M; Bekassy A N; Krivan G; Di Bartolomeo P; Heilmann C; Zanesco L; Cahn J Y; Arcese W; Bacigalupo A; Gluckman E
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.
Blood 2000;95(2):422-9.
2000: Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
Acta haematologica 2000;103(1):19-25.
1999: Wang F Z; Linde A; Dahl H; Ljungman P
Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation.
Bone marrow transplantation 1999;24(11):1201-6.
1999: Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients.
Bone marrow transplantation 1999;24(9):1033-5.
1999: Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan D W; Powles R L; Reiffers J; Samson J D; Stoppa A M; Vernant J P; Volin L; Wallvik J
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1999;24(7):741-5.
1999: Samuelsson J; Zackrisson H; Tokics L; Ljungman P; Lidbrink E; Pircher P; Larsson L
Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer.
Bone marrow transplantation 1999;23(8):835-7.
1999: Ringdén O; Remberger M; Ruutu T; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Mellander L; Ljungman P; Jacobsen N
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Blood 1999;93(7):2196-201.
1999: Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Blood 1999;93(7):2191-5.
1999: Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Annals of internal medicine 1999;130(3):193-201.
1999: Wang F Z; Dahl H; Ljungman P; Linde A
Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults.
Journal of medical virology 1999;57(2):134-9.
1999: Pauksen K; Sjölin J; Linde A; Andersson B; Lenkei R; Oberg G; Ljungman P
Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients.
Scandinavian journal of infectious diseases 1999;31(1):43-9.
1998: Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
Transplantation 1998;66(10):1330-4.
1998: Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn B M; Winiarski J; Ljungman P; Aschan J
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Hamarström V; Pauksen K; Svensson H; Oberg G; Paul C; Ljungman P
Tetanus immunity in patients with hematological malignancies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(5):469-72.
1998: Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn B M; Ljungman P
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Ljungman P; Halasz R; Hägglund H; Sönnerborg A; Ringdén O
Detection of hepatitis G virus/GB virus C after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(5):499-501.
1998: Larsson K; Björkstrand B; Ljungman P
Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(4):378-83.
1998: Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
Bone marrow transplantation 1998;22(1):67-71.
1998: Passweg J R; Rowlings P A; Atkinson K A; Barrett A J; Gale R P; Gratwohl A; Jacobsen N; Klein J P; Ljungman P; Russell J A; Schaefer U W; Sobocinski K A; Vossen J M; Zhang M J; Horowitz M M
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.
Bone marrow transplantation 1998;21(12):1231-8.
1998: Ljungman P
Immune reconstitution and viral infections after stem cell transplantation.
Bone marrow transplantation 1998;21 Suppl 2():S72-4.
1998: Guardiola P; Socié G; Pasquini R; Dokal I; Ortega J J; van Weel-Sipman M; Marsh J; Locatelli F; Souillet G; Cahn J Y; Ljungman P; Miniero R; Shaw J; Vermylen C; Archimbaud E; Bekassy A N; Krivan G; Di Bartolomeo P; Bacigalupo A; Gluckman E
Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21 Suppl 2():S24-7.
1998: Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Clinical transplantation 1998;12(2):84-92.
1998: Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel M P; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb H J; Aul C; Apperley J
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(3):255-61.
1998: Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1998: Gahrton G; Björkstrand B; Dilber M S; Sundman-Engberg B; Ljungman P; Smith C I
Gene marking and gene therapy in multiple myeloma.
Advances in experimental medicine and biology 1998;451():493-7.
1997: Ljungman P; Hassan M; Békássy A N; Ringdén O; Oberg G
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1997;20(11):909-13.
1997: Ljungman P; Hägglund H; Björkstrand B; Lönnqvist B; Ringdén O
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(6):485-8.
1997: Carlens S; Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Ljungman P
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Transplantation proceedings 1997;29(7):3147-9.
1997: Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Carlens S; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Pauksen K; Sjölin J; Linde A; Alm G; Andersson B; Lönnerholm G; Ljungman P
Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.
Bone marrow transplantation 1997;20(4):317-23.
1997: Devergie A; Apperley J F; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice H G; Jouet J P; Kolb H J; Herstenstein B; Bacigalupo A; Evensen S A; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark R E; Goldman J M; Gratwohl A
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1997;20(1):11-9.
1997: Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Bone marrow transplantation 1997;19(9):905-8.
1997: Ljungman P
Respiratory virus infections in bone marrow transplant recipients: the European perspective.
The American journal of medicine 1997;102(3A):44-7.
1997: Mattsson J; Ringdén O; Aschan J; Barkholt L; Dalianis T; Hägglund H; Ljungman P; Lönnqvist B; Tollemar J; Winiarski J; Remberger M
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Bone marrow transplantation 1997;19(3):233-6.
1996: Björkstrand B B; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Bladé J; Carlson K; Cavo M; Ferrant A; Goldstone A H; de Laurenzi A; Majolino I; Marcus R; Prentice H G; Remes K; Samson D; Sureda A; Verdonck L F; Volin L; Gahrton G
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.
Blood 1996;88(12):4711-8.
1996: Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Bone marrow transplantation 1996;18(6):1179-81.
1996: Pauksen K; Linde A; Lönnerholm G; Ljungman P; Sjölin J
Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients.
Bone marrow transplantation 1996;18(5):969-73.
1996: Wang F Z; Dahl H; Linde A; Brytting M; Ehrnst A; Ljungman P
Lymphotropic herpesviruses in allogeneic bone marrow transplantation.
Blood 1996;88(9):3615-20.
1996: Hágglund H; Ringdén O; Ericzon B G; Duraj F; Ljungman P; Lönnqvist B; Winiarski J; Tydén G
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Transplantation 1996;62(8):1076-80.
1996: Ljungman P; Oberg G; Aschan J; Ehrnst A; Lönnqvist B; Pauksen K; Sulila P
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;18(3):565-8.
1996: Ljungman P; Andersson J; Aschan J; Björkstrand B; Hägglund H; Lönnqvist B; Ringdén O; Winiarski J
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(1):167-9.
1996: Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1996;17(5):813-7.
1996: Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;17(4):583-7.
1996: Winiarski J; Ringdén O; Remberger M; Dalianis T; Ljungman P; Borgström B
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(3):327-35.
1995: Pauksen K; Linde A; Ljungman P; Bolme P; Lönnerholm G; Oberg G; Sjölin J
Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation.
Bone marrow transplantation 1995;16(6):807-13.
1995: Ljungman P
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Seminars in respiratory infections 1995;10(4):209-15.
1995: Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
Transplantation proceedings 1995;27(6):3531-2.
1995: Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg A S; Winiarski J; Andersson J; Ringdén O
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
Transplantation proceedings 1995;27(6):3530.
1995: Lönnqvist B; Ljungman P; Norrby M; Olerup O; Ringdén O; Winiarski J
Less acute GVHD in patients receiving totally matched transplants from unrelated donors.
Transplantation proceedings 1995;27(6):3528-9.
1995: Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Transplantation 1995;60(11):1225-30.
1995: Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist V A
Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
Transplantation 1995;60(9):961-5.
1995: Björkstrand B; Ljungman P; Bird J M; Samson D; Brandt L; Alegre A; Auzanneau G; Bladé J; Brunet S; Carlson K
Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():140-6.
1995: Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():122-5.
1995: Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G
Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
Blood 1995;86(4):1614-8.
1995: Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1312-22.
1995: Ljungman P; Hassan M; Békássy A N; Ringdén O; Oberg G
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Bone marrow transplantation 1995;15(6):869-71.
1995: Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Bone marrow transplantation 1995;15(4):619-25.
1995: Ljungman P; Cordonnier C; de Bock R; Einsele H; Engelhard D; Grundy J; Link H; Locasciulli A; Prentice G; Reusser P
Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1995;15(3):455-60.
1995: Björkstrand B; Ljungman P; Bird J M; Samson D; Gahrton G
Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.
Bone marrow transplantation 1995;15(3):367-71.
1995: Bolme P; Henter J I; Winiarski J; Elinder G; Ljungman P; Lönnerholm G; Ringdén O
Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden.
Bone marrow transplantation 1995;15(3):331-5.
1995: Ljungman P; Andersson J; Sparrelid E
[Infections following bone marrow transplantation]
Nordisk medicin 1995;110(12):320-1.
1994: Locasciulli A; Alberti A; de Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Reusser P; Ribaud P; Ljungman P
Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.
Bone marrow transplantation 1994;14(5):833-7.
1994: Björkstrand B; Goldstone A H; Ljungman P; Brandt L; Brunet S; Carlson K; Prentice G; Cavo M; Samson D; de Laurenzi A
Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow Transplantation.
Leukemia & lymphoma 1994;15(3-4):265-72.
1994: Ljungman P; Lawler M; Asjö B; Bogdanovic G; Karlsson K; Malm C; McCann S R; Ringdén O; Gahrton G
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.
British journal of haematology 1994;88(2):403-5.
1994: Ljungman P; Lewensohn-Fuchs I; Hammarström V; Aschan J; Brandt L; Bolme P; Lönnqvist B; Johansson N; Ringdén O; Gahrton G
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.
Blood 1994;84(2):657-63.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Lönnqvist B; Remberger M
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Marsh J C; Socie G; Schrezenmeier H; Tichelli A; Gluckman E; Ljungman P; McCann S R; Raghavachar A; Marin P; Hows J M
Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia.
Lancet 1994;344(8916):172-3.
1994: Palmblad J; Samuelsson J; Glimelius B; Ljungman P; Nilsson P G
[Myeloid growth factors. New indications with many questions]
Läkartidningen 1994;91(28-29):2675-8.
1994: Ringdén O; Remberger M; Persson U; Ljungman P; Aschan J; Bolme P; Dahllöf G; Dalianis T; Gahrton G; Lönnqvist B
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one]
Läkartidningen 1994;91(26-27):2577-82.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Transplantation proceedings 1994;26(3):1831-2.
1994: Remberger M; Ringden O; Aschan J; Ljungman P; Lönnqvist B; Markling L
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation proceedings 1994;26(3):1829-30.
1994: Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
Transplantation proceedings 1994;26(3):1827-8.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Remberger M
Prevention of graft-versus-host disease on an individual basis.
Transplantation proceedings 1994;26(3):1823-4.
1994: Boström L; Brytting M; Mousavi-Jazi M; Ringden O; Ljungman P; Lönnqvist B; Wahren B; Sundqvist V A
PCR detection of CMV DNA in peripheral blood leucocytes and plasma from BMT recipients.
Transplantation proceedings 1994;26(3):1723-4.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Blood 1994;83(9):2723-30.
1994: Pauksen K; Hammarström V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Magnius L; Simonsson B
Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(4):547-52.
1994: Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Bone marrow transplantation 1994;13(4):397-402.
1994: McCann S R; Bacigalupo A; Gluckman E; Hinterberger W; Hows J; Ljungman P; Marin P; Nissen C; van't Veer Kerthof E; Raghavachar A
Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.
Bone marrow transplantation 1994;13(3):233-7.
1994: Ljungman P; Biron P; Bosi A; Cahn J Y; Goldstone A H; Gorin N C; Link H; Messina C; Michallet M; Richard C
Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation.
Bone marrow transplantation 1994;13(2):209-12.
1993: Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Bone marrow transplantation 1993;12(6):577-82.
1993: Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann S R; Frickhofen N; Van't Veer-Korthof E; Gluckman E
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
The New England journal of medicine 1993;329(16):1152-7.
1993: Schrezenmeier H; Marin P; Raghavachar A; McCann S; Hows J; Gluckman E; Nissen C; van't Veer-Korthof E T; Ljungman P; Hinterberger W
Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party.
British journal of haematology 1993;85(2):371-7.
1993: Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Bone marrow transplantation 1993;12(4):399-403.
1993: Ljungman P; Andersson J; Aschan J; Barkholt L; Ehrnst A; Johansson M; Weiland O
Influenza A in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(2):244-7.
1993: Hammarström V; Pauksen K; Azinge J; Oberg G; Ljungman P
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(4):195-9.
1993: Lolli F; Sundqvist V A; Castagna A; Ljungman P; Linde A; Andersson G; Olsson T; Wahren B
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients.
FEMS immunology and medical microbiology 1993;7(1):55-62.
1993: Ljungman P; de Witte T; Verdonck L; Gahrton G; Freycon F; Gravett P; McCann S; Morgenstern H G; Nikoskelainen J; Powles R
Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing.
British journal of haematology 1993;84(1):61-6.
1993: Aschan J; Ringdén O; Sundberg B; Klaesson S; Ljungman P; Lönnqvist B
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
European journal of haematology 1993;50(5):269-74.
1993: Lönnqvist B; Palmblad J; Ljungman P; Grimfors G; Järnmark M; Lerner R; Nyström-Rosander C; Oberg G
Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(3):139-44.
1993: Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Sparrelid E; Tydén G
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
Transplantation proceedings 1993;25(1 Pt 2):1495-7.
1993: Ehrnst A; Barkholt L; Brattström C; Czajkowski J; Teodosiu O; Tollemar J; Ljungman P
Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease.
Journal of medical virology 1993;39(2):118-24.
1993: Ljungman P; Aschan J; Azinge J N; Brandt L; Ehrnst A; Hammarström V; Klaesson S; Linde A; Lönnqvist B; Ringdén O
Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation.
British journal of haematology 1993;83(1):118-24.
1992: Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(6):427-32.
1992: Ljungman P; Gahrton G
Bone marrow transplantation for acute non-lymphoblastic leukemia.
Leukemia & lymphoma 1992;7(1-2):7-14.
1992: Palmblad J; Lönnqvist B; Carlsson B; Grimfors G; Järnmark M; Lerner R; Ljungman P; Nyström-Rosander C; Petrini B; Oberg G
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.
Journal of internal medicine 1992;231(4):363-70.
1992: Socié G; Kolb H J; Ljungman P
Malignant diseases after allogeneic bone marrow transplantation: the case for assessment of risk factors.
British journal of haematology 1992;80(4):427-30.
1992: Ljungman P; Engelhard D; Link H; Biron P; Brandt L; Brunet S; Cordonnier C; Debusscher L; de Laurenzi A; Kolb H J
Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(4):831-5.
1992: Mattsson T; Arvidson K; Heimdahl A; Ljungman P; Dahllof G; Ringdén O
Alterations in taste acuity associated with allogeneic bone marrow transplantation.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(1):33-7.
1992: Ringdén O; Klaesson S; Sundberg B; Ljungman P; Lönnqvist B; Persson U
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Bone marrow transplantation 1992;9(1):19-25.
1992: Mathiesen T; Brattström C; Andersson J; Linde A; Ljungman P; Wahren B
Immunoglobulin G subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections.
Journal of medical virology 1992;36(1):65-9.
1992: Samuelsson J; Lönnqvist B; Palmblad J; Grimfors G; Järnmark M; Lerner R; Ljungman P; Nyström-Rosander C; Oberg G
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Scandinavian journal of infectious diseases 1992;24(1):89-96.
1992: Mattsson T; Sundqvist K G; Heimdahl A; Dahllöf G; Ljungman P; Ringdén O
A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus.
Archives of oral biology 1992;37(7):539-47.
1992: Aschan J; Ringdén O; Ljungman P; Lönnqvist B; Ohlman S
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1992;24(2):143-50.
1991: Ljungman P; Aschan J; Bolme P; Lindqvist R; Lönnqvist B; Ringdén O; Winiarski J; Gahrton G
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life]
Läkartidningen 1991;88(25):2308-11.
1991: Ringdén O; Pihlstedt P; Markling L; Aschan J; Båryd I; Ljungman P; Lönnqvist B; Tollemar J; Janossy G; Sundberg B
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Bone marrow transplantation 1991;7(3):221-6.
1991: Aschan J; Ringdén O; Sundberg B; Gahrton G; Ljungman P; Winiarski J
Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Bone marrow transplantation 1991;7(2):113-9.
1991: Ljungman P; Duraj V; Magnius L
Response to immunization against polio after allogeneic marrow transplantation.
Bone marrow transplantation 1991;7(2):89-93.
1991: Gahrton G; Tura S; Ljungman P; Belanger B; Brandt L; Cavo M; Chapuis B; De Laurenzi A; de Witte T; Facon T
Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study.
Bone marrow transplantation 1991;7 Suppl 2():32.
1990: Ljungman P; Wiklund-Hammarsten M; Duraj V; Hammarström L; Lönnqvist B; Paulin T; Ringdén O; Pepe M S; Gahrton G
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
The Journal of infectious diseases 1990;162(2):496-500.
1990: Ringdén O; Groth C G; Aschan J; Bolme P; Ljungman P; Lönnqvist B; Malm G; Månsson J E; Shanwell A; Svennerholm L
Bone marrow transplantation for metabolic disorders at Huddinge Hospital.
Transplantation proceedings 1990;22(1):198-202.
1990: Aschan J; Ringdén O; Tollemar J; Ljungman P; Lönnqvist B; Pihlstedt P; Markling L; Sundberg B
Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.
Transplantation proceedings 1990;22(1):195-7.
1990: Ljungman P; Ehrnst A; Björkstrand B; Hellström E; Ingelman-Sundberg H; Juliusson G; Lönnqvist B
Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia.
Scandinavian journal of infectious diseases 1990;22(5):601-5.
1989: Ljungman P; Lönnqvist B; Ringdén O; Skinhöj P; Gahrton G
A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.
Bone marrow transplantation 1989;4(6):613-5.
1989: Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Pretransplant herpes virus serology and chronic graft-versus-host disease.
Bone marrow transplantation 1989;4(5):547-52.
1989: Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
The Journal of infectious diseases 1989;159(4):610-5.
1989: Aschan J; Ringdén O; Ljungman P; Andersson J; Lewensohn-Fuchs I; Forsgren M
Influenza B in transplant patients.
Scandinavian journal of infectious diseases 1989;21(3):349-50.
1988: Ljungman P; Zetterqvist L; Sundqvist V A; Jeansson S; Heimdahl A; Wahren B
Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.
Clinical and experimental immunology 1988;72(2):207-10.
1987: Ost L; Lönnqvist B; Eriksson L; Ljungman P; Ringdén O
Hemorrhagic cystitis--a manifestation of graft versus host disease?
Bone marrow transplantation 1987;2(1):19-25.
1986: Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
Bone marrow transplantation 1986;1(2):185-92.

Sign-in to see more